ID

34244

Description

Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01226888

Lien

https://clinicaltrials.gov/show/NCT01226888

Mots-clés

  1. 15/01/2019 15/01/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

15 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT01226888

Eligibility Prostate Cancer NCT01226888

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adenocarcinoma of the prostate
Description

Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
scheduled to initiate gnrh agonist or antagonist treatment with an intended treatment duration of 12 months or greater
Description

GnRH Agonist Scheduled | GnRH antagonist Scheduled

Type de données

boolean

Alias
UMLS CUI [1,1]
C2267073
UMLS CUI [1,2]
C0205539
UMLS CUI [2,1]
C1268855
UMLS CUI [2,2]
C0205539
ecog performance status of 0 or 1
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
ability to understand and the willingness to sign a written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
65 years of age or younger
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
diagnosis of diabetes
Description

Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
ongoing corticosteroid use
Description

Adrenal Cortex Hormones

Type de données

boolean

Alias
UMLS CUI [1]
C0001617
gnrh agonist or antagonist treatment within the last 2 years
Description

GnRH Agonist | GnRH antagonist

Type de données

boolean

Alias
UMLS CUI [1]
C2267073
UMLS CUI [2]
C1268855
ongoing beta-blocker use
Description

Adrenergic beta-1 Receptor Antagonists

Type de données

boolean

Alias
UMLS CUI [1]
C0304516
body mass index of greater than 30
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855

Similar models

Eligibility Prostate Cancer NCT01226888

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
GnRH Agonist Scheduled | GnRH antagonist Scheduled
Item
scheduled to initiate gnrh agonist or antagonist treatment with an intended treatment duration of 12 months or greater
boolean
C2267073 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
C1268855 (UMLS CUI [2,1])
C0205539 (UMLS CUI [2,2])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
ability to understand and the willingness to sign a written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
65 years of age or younger
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus
Item
diagnosis of diabetes
boolean
C0011849 (UMLS CUI [1])
Adrenal Cortex Hormones
Item
ongoing corticosteroid use
boolean
C0001617 (UMLS CUI [1])
GnRH Agonist | GnRH antagonist
Item
gnrh agonist or antagonist treatment within the last 2 years
boolean
C2267073 (UMLS CUI [1])
C1268855 (UMLS CUI [2])
Adrenergic beta-1 Receptor Antagonists
Item
ongoing beta-blocker use
boolean
C0304516 (UMLS CUI [1])
Body mass index
Item
body mass index of greater than 30
boolean
C1305855 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial